[Fibrinolytic therapy of pulmonary embolism in pregnant women].
D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008428:Maternal Mortality; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D011256:Pregnancy Outcome; D018566:Pregnancy, High-Risk; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D012307:Risk Factors; D015912:Thrombolytic Therapy
D000925:Anticoagulants; D005343:Fibrinolytic Agents
Fibrynolityczne leczenie zatorowości płucnej w ciazy -- współczesne poglady.